ZC4H2 (Zinc finger C4H2-type) is a protein-coding gene located on the X-chromosome. This gene encodes a protein which is a member of the so-called zinc finger domain-containing protein family. There is currently very limited understanding about the ZC4H2 gene and its protein function. Any pathogenic variant of ZC4H2 which is associated with a clinical phenotype is referred to as "ZC4H2 Deficiency".[a] The limited research published to date indicates that ZC4H2 is expressed at various developmental stages and is subject to X-inactivation in females. There are a few families and singletons (males and females) with pathogenic variants of ZC4H2 described in the medical literature.      Â In the families the variants can be transmitted as an X-linked recessive trait, which means that the disorder is fully expressed predominantly in males, while their carrier female siblings are unaffected or much less severely affected. In contrast to these females, heterozygous de novo variants in ZC4H2 in singleton females can result in a specific phenotype. It is believed that the pathogenic variants of ZC4H2 may result in impairment of the central and peripheral nervous system through the impairment of neurologic development and/or synaptic plasticity.  Studies in zebrafish showed that the homologue of human ZC4H2 is associated with the generation of a specific subset of central nervous system interneurons.  Besides the cases described in the current literature, an additional 46 diagnosed cases of males and females with ZC4H2 Deficiency are known worldwide, constituting this an ultra-rare orphan disorder. There is no clear prediction of the phenotypic expression but it is  known that the disorder can be fully expressed in males, while the clinical presentation in singleton females who have a de novo variant can be very variable. Patients with this condition can have several disabilities and health concerns, including a large array of neuromuscular and neurological manifestations. These can include: To date, there is no cure or effective treatment for this condition. Current approach is limited to supportive therapies and interventions. 